Found: 52
Select item for more details and to access through your institution.
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13045-020-00953-8
- By:
- Publication type:
- Article
The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Treatment of hematologic malignancies with alternate hemibody irradiation combined with high-dose chemotherapy: a single-center experience.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.
- Published in:
- Stem Cell Research & Therapy, 2015, v. 6, n. 1, p. 1, doi. 10.1186/s13287-015-0164-4
- By:
- Publication type:
- Article
Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 5, p. 862, doi. 10.1111/bjh.17703
- By:
- Publication type:
- Article
Risk of hepatitis B reactivation is controllable in patients with B‐cell lymphoma receiving anti‐CD19 CAR T cell therapy.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. 126, doi. 10.1111/bjh.16951
- By:
- Publication type:
- Article
BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase.
- Published in:
- BMC Medical Genetics, 2017, v. 18, p. 1, doi. 10.1186/s12881-017-0381-z
- By:
- Publication type:
- Article
Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 4, p. 606, doi. 10.1007/s10637-023-01376-1
- By:
- Publication type:
- Article
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 523, doi. 10.1002/ajh.27207
- By:
- Publication type:
- Article
Preliminary efficacy and safety of Relmacabtagene autoleucel (Carteyva) in adults with relapsed/refractory follicular lymphoma in China: A phase I/II clinical trial.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E436, doi. 10.1002/ajh.26711
- By:
- Publication type:
- Article
Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 6, p. 2073, doi. 10.1007/s00277-024-05719-7
- By:
- Publication type:
- Article
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM).
- Published in:
- Annals of Hematology, 2024, v. 103, n. 4, p. 1305, doi. 10.1007/s00277-023-05573-z
- By:
- Publication type:
- Article
Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: a case report and literature review.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 339, doi. 10.1007/s00277-023-05465-2
- By:
- Publication type:
- Article
Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 6, p. 1201, doi. 10.1007/s00277-022-04795-x
- By:
- Publication type:
- Article
Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 2, p. 257, doi. 10.1007/s00277-014-2211-0
- By:
- Publication type:
- Article
Treatment and Prognosis of Adult T Cell Acute Lymphoblastic Leukemia.
- Published in:
- Acta Academiae Medicinae Sinica, 2019, v. 41, n. 4, p. 485, doi. 10.3881/j.issn.1000-503X.10807
- By:
- Publication type:
- Article
Mechanochemical coupling of MGF mediates periodontal regeneration.
- Published in:
- Bioengineering & Translational Medicine, 2024, v. 9, n. 1, p. 1, doi. 10.1002/btm2.10603
- By:
- Publication type:
- Article
Gemcitabine‐based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non‐Hodgkin lymphoma: No difference in outcomes.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 2, p. 1, doi. 10.1002/cam4.6965
- By:
- Publication type:
- Article
Long‐term outcomes of second‐line versus later‐line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 18643, doi. 10.1002/cam4.6473
- By:
- Publication type:
- Article
Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 3, p. 999, doi. 10.1002/cam4.3686
- By:
- Publication type:
- Article
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1184395
- By:
- Publication type:
- Article
Minimal residual disease status improved the response evaluation in patients with Waldenström’s macroglobulinemia.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1171539
- By:
- Publication type:
- Article
Crystal-storing histiocytosis: a clinicopathological study of 13 cases.
- Published in:
- Histopathology, 2016, v. 68, n. 4, p. 482, doi. 10.1111/his.12768
- By:
- Publication type:
- Article
P-174: Clinical study of bortezomib-based regimens of BCD, PAD and VDD for newly diagnosed multiple myeloma – an analysis of 400 cases in a single center of China.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S131, doi. 10.1016/S2152-2650(21)02301-6
- By:
- Publication type:
- Article
P-088: Indirubin-3'-monoxime acts as an alternative proteasome inhibitor and confers new regimens for the treatment of Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S87, doi. 10.1016/S2152-2650(21)02222-9
- By:
- Publication type:
- Article
Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in China.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Subtype Distribution, Clinical Features, and Survival in B-cell Chronic Lymphoproliferative Disorders in China: A Review of 1592 Cases.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical Characteristics, Survival Outcomes and prognosis in 82 Immunoglobulin D Multiple Myeloma Patients: A Retrospective Single-Center Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e304, doi. 10.1016/j.clml.2019.09.499
- By:
- Publication type:
- Article
A Phase 3 Study of Carfilzomib and Dexamethasone (Kd) in Patients With Relapsed and Refractory Multiple Myeloma (MM) in China.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e267, doi. 10.1016/j.clml.2019.09.441
- By:
- Publication type:
- Article
The prognostic value of 1q21 gain does not rely on the copy numbers, clone size and concurrence with t(4;14).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e62, doi. 10.1016/j.clml.2019.09.097
- By:
- Publication type:
- Article
PHF19 Promotes Drug Resistance via Increased EZH2 Phosphorylation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e21, doi. 10.1016/j.clml.2019.09.031
- By:
- Publication type:
- Article
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
- Published in:
- Annals of Hematology, 2009, v. 88, n. 11, p. 1069, doi. 10.1007/s00277-009-0720-z
- By:
- Publication type:
- Article
A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 3, p. 422, doi. 10.1007/s12185-020-03044-z
- By:
- Publication type:
- Article
Regulation of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma.
- Published in:
- Molecular Carcinogenesis, 2015, v. 54, n. 10, p. 1060, doi. 10.1002/mc.22175
- By:
- Publication type:
- Article
A pivotal role of bone remodeling in granulocyte colony stimulating factor induced hematopoietic stem/progenitor cells mobilization.
- Published in:
- Journal of Cellular Physiology, 2013, v. 228, n. 5, p. 1002, doi. 10.1002/jcp.24246
- By:
- Publication type:
- Article
Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus‐associated mantle cell lymphoma.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 3, p. 1, doi. 10.1002/hon.3268
- By:
- Publication type:
- Article
A novel clinical immune‐related prognostic model predicts the overall survival of mantle cell lymphoma.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 3, p. 343, doi. 10.1002/hon.2994
- By:
- Publication type:
- Article
Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 1, p. N.PAG, doi. 10.1002/cti2.1105
- By:
- Publication type:
- Article
Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.
- Published in:
- Stem Cell Research & Therapy, 2015, v. 6, p. 1, doi. 10.1186/s13287-015-0164-4
- By:
- Publication type:
- Article
Effects of incorporation of granule-lyophilised platelet-rich fibrin into polyvinyl alcohol hydrogel on wound healing.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32208-5
- By:
- Publication type:
- Article
Application patterns and outcomes of hematopoietic stem cell transplantation in peripheral T-cell lymphoma patients: a multicenter real-world study in China.
- Published in:
- 2024
- By:
- Publication type:
- Letter
The Significance of Bone Marrow Involvement in Aggressive Lymphomas: A Retrospective Comparison of Clinical Outcomes between Peripheral T Cell Lymphoma and Diffuse Large B Cell Lymphoma in China.
- Published in:
- Acta Haematologica, 2010, v. 124, n. 4, p. 239, doi. 10.1159/000321544
- By:
- Publication type:
- Article
Clinical Characteristics and Treatment Outcome of Adult Acute Lymphoblastic Leukemia with t(4;11)(q21;q23) Using a Modified Hyper-CVAD Regimen.
- Published in:
- Acta Haematologica, 2009, v. 122, n. 1, p. 23, doi. 10.1159/000232579
- By:
- Publication type:
- Article
A Retrospective Analysis of Thirty-One Cases of Plasma Cell Leukemia from a Single Center in China.
- Published in:
- Acta Haematologica, 2009, v. 121, n. 1, p. 47, doi. 10.1159/000210555
- By:
- Publication type:
- Article
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01174-3
- By:
- Publication type:
- Article
Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 3, p. 421, doi. 10.1002/cncr.35056
- By:
- Publication type:
- Article
Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in China.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1534-0
- By:
- Publication type:
- Article
Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in China.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 555, doi. 10.1186/s12885-015-1534-0
- By:
- Publication type:
- Article